ArticleSouth Asian journal of cancer2023

Phase 1/2 Study of the Timing and Efficacy of 3 mg Peg-GCSF in Neo/Adjuvant Dose Dense Breast Cancer Treatment Protocols.

Amol Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.